Anurag Relan

Anurag Relan practices at Providence Medical Institute in Manhattan Beach, California.

Anurag Relan's NPI, 1730102104, was assigned on July 25, 2006. Anurag Relan graduated from David Geffen School of Medicine at UCLA in 1999. Anurag Relan holds California license A73796.

Anurag Relan's primary practice is Providence Medical Institute, at 1010 N Sepulveda Blvd, Manhattan Beach, CA 90266 in Los Angeles County. The practice phone is (310) 793-8075.

Anurag Relan's primary practice is Providence Medical Institute in Manhattan Beach, California. The medical group on file is Providence Medical Institute. Dmand AI also links Anurag Relan to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Anurag Relan practices, 2 sites in all. Vendor and product names are available with a free account.

Family medicine is Anurag Relan's primary specialty in the NPI Registry, under taxonomy code 207Q00000X. Anurag Relan is board certified in family medicine by the American Board of Family Medicine. Anurag Relan is licensed in California.

Dmand AI lists acute sinusitis, acute skin infection, head wound, shingles, swimmer's ear and upper respiratory infection (URI) among the conditions Anurag Relan treats.

CMS data shows 13 Medicare services from Anurag Relan across 1 procedure code in 2024, all of them office visits, for 19 Medicare patients. Medicare paid $813 for them. Every service was in an office.

CMS counts 19 Medicare patients who saw Anurag Relan in 2024. The largest group is under 65, with 0 patients. 75% of them have high cholesterol, and 58% have arthritis. Their average risk score is 1.11, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Anurag Relan's median patient age at 44, with 58% women.

In 2024, Anurag Relan wrote 17 Medicare Part D claims for 15 patients. 94% of them were for generic drugs. They cover 2 drugs, with $236 in total drug cost. In 2018, CMS named 11 claims across 1 drug.

Anurag Relan accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 45 papers to Anurag Relan, published from 2011 to 2025. 2016 was the busiest year, with 5. The most frequent topics are Complement C1 Inhibitor Protein, Angioedemas, Hereditary and Recombinant Proteins. Anurag Relan has published most often in Ann Allergy Asthma Immunol. Anurag Relan's most frequent co-authors are Marc Andrew Riedl, MD, Bruce L. Zuraw, MD and James W. Baker, MD.

Dmand AI links Anurag Relan to 8 clinical trials, 3 of them phase 2 studies. Conditions studied include Hereditary Complement Deficiency Diseases, Angioedemas, Hereditary and Genetic Diseases, Inborn. Pharming Technologies B.V. sponsors the most, 8.

CMS Open Payments shows 2 general payments to Anurag Relan from 1 drug or device company in 2016. Food and beverage make up the largest share, 100% of the total. Valeant Pharmaceuticals International paid the most, $32.

Anurag Relan graduated from David Geffen School of Medicine at UCLA in 1999.

Anurag Relan is in network with 12 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.